'Fast-fail' AI blood test could steer patients with pancreatic cancer away from ineffective therapies
10 months ago
140
ARTICLE AD BOX
An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood could help clinicians more quickly identify and determine if pancreatic cancer therapies are working.